PHARMACEUTICAL - 2697 ads
401120 MedicalReport abuse
Friday, July 25, 2025
Quantity : 15mg*10via - Price : USD 150
Tirzepatide shares a similar sequence to semaglutide, with the lys side chain of the sequence bearing a PEG modification, which is a functional group of the peptide, as well as the ability to increase the water solubility of the sequence.The primary physiological function of TirzepaChemicalbookti...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MedicalReport abuse
Friday, July 25, 2025
Quantity : 10mg*10via - Price : USD 110
Tirzepatide shares a similar sequence to semaglutide, with the lys side chain of the sequence bearing a PEG modification, which is a functional group of the peptide, as well as the ability to increase the water solubility of the sequence.The primary physiological function of TirzepaChemicalbookti...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MedicalReport abuse
Friday, July 25, 2025
Quantity : 5mg*10vial - Price : USD 80
Tirzepatide shares a similar sequence to semaglutide, with the lys side chain of the sequence bearing a PEG modification, which is a functional group of the peptide, as well as the ability to increase the water solubility of the sequence.The primary physiological function of TirzepaChemicalbookti...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MedicalReport abuse
Friday, July 25, 2025
Quantity : 60mg*10via - Price : USD 650
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MedicalReport abuse
Friday, July 25, 2025
Quantity : 50mg*10via - Price : USD 550
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MedicalReport abuse
Friday, July 25, 2025
Quantity : 40mg*10via - Price : USD 450
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
